Ixekizumab met psoriasis endpoints by week 12, with durable response at 60 weeksApril 9, 2015Psoriatic Arthritis
Methotrexate and biologics linked to higher zoster risk in psoriasisMarch 22, 2015Psoriatic Arthritis
Secukinumab beat ustekinumab for psoriasis, with difference by week fourMarch 21, 2015Psoriatic Arthritis
